S'abonner

Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening - 10/02/22

Doi : 10.1016/j.amjsurg.2021.04.005 
Nikhil K. Prasad a, b, Rachel Lake a, b, Brian R. Englum a, Douglas J. Turner a, b, Tariq Siddiqui b, Minerva Mayorga-Carlin a, b, John D. Sorkin c, d, Brajesh K. Lal a, b,
a Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA 
b Surgery Service, Veterans Affairs Medical Center, Baltimore, MD, USA 
c Geriatrics Research, Education, and Clinical Center, Veterans Affairs Medical Center, Baltimore, MD, USA 
d Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA 

Corresponding author. Department of Surgery, University of Maryland, 22 South Greene Street, Baltimore, MD, 21201, USA.Department of SurgeryUniversity of Maryland22 South Greene StreetBaltimoreMD21201USA

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

The COVID-19 pandemic has necessitated the adoption of protocols to minimize risk of periprocedural complications associated with SARS-CoV-2 infection. This typically involves a preoperative symptom screen and nasal swab RT-PCR test for viral RNA. Asymptomatic patients with a negative COVID-19 test are cleared for surgery. However, little is known about the rate of postoperative COVID-19 positivity among elective surgical patients, risk factors for this group and rate of complications.

Methods

This prospective multicenter study included all patients undergoing elective surgery at 170 Veterans Health Administration (VA) hospitals across the United States. Patients were divided into groups based on first positive COVID-19 test within 30 days after surgery (COVID[-/+]), before surgery (COVID[+/−]) or negative throughout (COVID[−/−]). The cumulative incidence, risk factors for and complications of COVID[-/+], were estimated using univariate analysis, exact matching, and multivariable regression.

Results

Between March 1 and December 1, 2020 90,093 patients underwent elective surgery. Of these, 60,853 met inclusion criteria, of which 310 (0.5%) were in the COVID[-/+] group. Adjusted multivariable logistic regression identified female sex, end stage renal disease, chronic obstructive pulmonary disease, congestive heart failure, cancer, cirrhosis, and undergoing neurosurgical procedures as risk factors for being in the COVID[-/+] group. After matching on current procedural terminology code and month of procedure, multivariable Poisson regression estimated the complication rate ratio for the COVID[-/+] group vs. COVID[−/−] to be 8.4 (C.I. 4.9–14.4) for pulmonary complications, 3.0 (2.2, 4.1) for major complications, and 2.6 (1.9, 3.4) for any complication.

Discussion

Despite preoperative COVID-19 screening, there remains a risk of COVID infection within 30 days after elective surgery. This risk is increased for patients with a high comorbidity burden and those undergoing neurosurgical procedures. Higher intensity preoperative screening and closer postoperative monitoring is warranted in such patients because they have a significantly elevated risk of postoperative complications.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Image 1

Le texte complet de cet article est disponible en PDF.

Highlights

Incidence of COVID-19 positive within 30 days after elective surgery is 0.5%.
Top 3 risk factors include dialysis, heart failure, and liver cirrhosis.
Higher rates of pulmonary and major complications.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19 testing, Postoperative complications, Elective surgical procedure


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 223 - N° 2

P. 380-387 - février 2022 Retour au numéro
Article précédent Article précédent
  • Biologic mesh is non-inferior to synthetic mesh in CDC class 1 & 2 open abdominal wall reconstruction
  • Jenny M. Shao, Sullivan A. Ayuso, Eva B. Deerenberg, Sharbel A. Elhage, Tanu Prasad, Paul D. Colavita, Vedra A. Augenstein, B. Todd Heniford
| Article suivant Article suivant
  • Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS
  • Lauren A. Raff, Trista D. Reid, Daniel Johnson, Evan J. Raff, Andrew B. Schneider, Anthony G. Charles, Jared R. Gallaher

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.